Free Trial
→ Trump’s new nightmare begins (From Porter & Company) (Ad)tc pixel

TerrAscend (OTCMKTS:TRSSF) Stock Price Down 0.6% - Should You Sell?

Written by MarketBeat
September 26, 2025
TerrAscend logo with Medical background

Key Points

  • TerrAscend Corp. (OTCMKTS:TRSSF) experienced a 0.6% decline in stock price, trading last at $0.79, with a volume increase of 274% compared to its average session.
  • The company focuses on cultivating, processing, and selling medical and adult-use cannabis in North America, and also distributes hemp-derived wellness products.
  • TerrAscend's current ratio stands at 0.73 and its debt-to-equity ratio is 0.55, indicating potential liquidity concerns.
  • Five stocks to consider instead of TerrAscend.

TerrAscend Corp. (OTCMKTS:TRSSF - Get Free Report)'s stock price fell 0.6% on Thursday . The company traded as low as $0.78 and last traded at $0.79. 490,076 shares changed hands during trading, an increase of 274% from the average session volume of 131,026 shares. The stock had previously closed at $0.79.

TerrAscend Price Performance

The business's 50-day simple moving average is $0.74 and its two-hundred day simple moving average is $0.48. The company has a current ratio of 0.73, a quick ratio of 0.40 and a debt-to-equity ratio of 0.55.

About TerrAscend

(Get Free Report)

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis-infused artisan edibles. It also operates retail dispensaries under the Apothecarium brand name in California, Pennsylvania, and New Jersey.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in TerrAscend Right Now?

Before you consider TerrAscend, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TerrAscend wasn't on the list.

While TerrAscend currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.